← Open Payments lookup

MARK BLIZZARD: Open Payments

NPI 1043945041 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,925 in 112 payments from 26 companies in 2025. Trend: 2023 $1,816 · 2024 $1,815 · 2025 $1,925

Food & beverage: $1,925
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$248
Astellas Pharma US Inc9$164
Novo Nordisk Inc10$150
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$142
Aimmune Therapeutics, Inc.6$132
Corcept Therapeutics6$120
Ardelyx, Inc.7$119
ABBVIE INC.5$98
Bayer Healthcare Pharmaceuticals Inc.5$90
Phathom Pharmaceuticals, Inc.4$80

Products named: BREZTRI, Veozah, XIFAXAN, ZENPEP, Korlym, IBSRELA, REXULTI, Kerendia.

Industry payments across NC — which companies pay providers there.